Skip to content

ASEPTIC TECHNOLOGIES

Active
Public limited companyfounded 200224 yrs activeRue Camille Hubert,Isnes 7-9, 5032 Gembloux, BelgiumKBO/BCE: BE 0477.899.303
Summary

ASEPTIC TECHNOLOGIES has been active since 2002 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €38.5m and a net result of €15.0m. Equity is growing by ~33.2% per year across the filed fiscal years. Its solvency ranks better than 77% of 316 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.4% (very low).

Checked score

Score 2024
Axes · tick = 2023
Profitability99▲+6
Solvency86▲+8
Growth85=
Track record100
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2,000,000 at 30 days acceptable
Liquidity ample (current ratio 2.4 against 1.83 in 2023; short-term debt: 34.2% and cash: 25.3% of total assets), and 38.5% of the assets are financed with debt.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 24 years 0 30 y
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
61.5%
Return on assets
24%
Age of the figures
21 mo
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 17-07-2025, 14 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
14 d early
2023
30 d early
2022
21 d early
2021
11 d late
2020
25 d early
2019
24 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 17 days before the deadline; the sector median for financial year 2024 is 11 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 4 July 2002, ASEPTIC TECHNOLOGIES was incorporated.1 A capital increase in 2011 brought the capital to EUR 50 million.2 PLAST4LIFE was merged into the company in 2025.3 Of the 6 current board members, SPARAXIS has served longest, since 2011.4

  1. 1Crossroads Bank for Enterprises
  2. 2Belgian State Gazette, 21-06-2011
  3. 3Belgian State Gazette, 17-07-2025
  4. 4Belgian State Gazette, 12-12-2024

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, full schema

Turnover
€41.9m▲ 57.2%
2023 · €26.6m
EBIT margin
37.0%▼ 5.6pp
2023 · 42.6%
Net result
€15.0m▲ 56.4%
2023 · €9.6m
Working capital
€29.9m▲ 43.1%
2023 · €20.9m
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20202021202220232024
Turnover€19.5m▲ 75.1%€22.6m▲ 15.9%€23.0m▲ 1.6%€26.6m▲ 15.8%€41.9m▲ 57.2%
Operating result€6.2m▲ 127%€7.1m▲ 15.6%€8.2m▲ 15.2%€11.3m▲ 38.0%€15.5m▲ 36.5%
Net result€6.0m▲ 118%€7.0m▲ 16.5%€7.9m▲ 13.7%€9.6m▲ 20.8%€15.0m▲ 56.4%
EBIT margin31.6%▲ 7.2pp31.5%▼ 0.1pp35.7%▲ 4.2pp42.6%▲ 6.9pp37.0%▼ 5.6pp
Equity€13.5m▲ 46.6%€18.5m▲ 37.0%€24.2m▲ 30.7%€31.0m▲ 28.4%€38.5m▲ 24.2%
Total assets€24.5m▲ 36.7%€31.3m▲ 27.8%€42.3m▲ 35.0%€58.5m▲ 38.2%€62.6m▲ 7.1%
Debt€8.0m▲ 30.2%€10.0m▲ 24.3%€15.7m▲ 56.6%€25.4m▲ 62.1%€22.0m▼ 13.3%
Working capital€11.1m▲ 70.5%€14.3m▲ 28.4%€15.7m▲ 10.0%€20.9m▲ 33.2%€29.9m▲ 43.1%
Staff (FTE)25.2▲ 28.6%31.9▲ 26.6%35.5▲ 11.3%40.8▲ 14.9%47.7▲ 16.9%
Result per fiscal year
Operating resultNet result
€0€5.0m€10.0m€15.0mOperating result 2020: €6.2m€6.2mNet result 2020: €6.0m€6.0mOperating result 2021: €7.1m€7.1mNet result 2021: €7.0m€7.0mOperating result 2022: €8.2m€8.2mNet result 2022: €7.9m€7.9mOperating result 2023: €11.3m€11.3mNet result 2023: €9.6m€9.6mOperating result 2024: €15.5m€15.5mNet result 2024: €15.0m€15.0m20202021202220232024€0€5m€10m€15mOperating result 2022: €8.2m€8.2mNet result 2022: €7.9m€7.9mOperating result 2023: €11.3m€11mNet result 2023: €9.6m€9.6mOperating result 2024: €15.5m€15mNet result 2024: €15.0m€15m202220232024
The operating result has risen four years in a row; 2024 is 36% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €62.6m
Fixed assets €11.3m ▼ 9.5%
Current assets €51.3m ▲ 11.6%
Equity and liabilities €62.6m
Equity €38.5m ▲ 24.2%
Provisions €2.1m ▲ 0.5%
Debt €22.0m ▼ 13.3%
Debt's share of the balance-sheet total falls from 43.4% to 35.1%. Equity is higher and debt is lower.
Key figures and ratios
2024 value · change against 2023
EBITDA
€18.3m▲
2023 · €13.8m
Cash flow
€17.8m▲
2023 · €12.0m
Current ratio
2.40▲
2023 · 1.83
Quick ratio
1.56▲
2023 · 1.06
Debt to equity
0.57▼
2023 · 0.82
ROE
39.0%▲
2023 · 31.0%
ROA
24.0%▲
2023 · 16.4%
Interest coverage
95.94▼
2023 · 146.56
Debt ≤ 1 year
€21.4m▼
2023 · €25.1m
Income taxes
€998,666▼
2023 · €1.3m
Staff costs
€5.2m▲
2023 · €4.6m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 20,082 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 95% are still going.

  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.2% went bankrupt
4.7% stopped otherwise
95% still going

For this company itself Checked computes a bankruptcy probability of 0.4% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.6%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 20,082 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 93 lines
Balance sheet Code20232024
Assets
Total assets20/58€58.5m€62.6m▲
Fixed assets21/28€12.5m€11.3m▼
Intangible fixed assets21€1.8m€1.7m▼
Tangible fixed assets22/27€9.2m€8.8m▼
Land and buildings22€177,110€177,110=
Plant, machinery and equipment23€1.0m€1.8m▲
Furniture and vehicles24€49,699€96,650▲
Other tangible fixed assets26€1.4m€448,564▼
Assets under construction and advance payments27€6.5m€6.3m▼
Financial fixed assets28€1.5m€830,921▼
Affiliated companies280/1€1.3m€630,000▼
Participating interests280€630,000€630,000=
Amounts receivable281€650,000-
Other financial fixed assets284/8€200,171€200,921▲
Amounts receivable and cash guarantees285/8€200,171€200,921▲
Current assets29/58€46.0m€51.3m▲
Stocks and contracts in progress3€19.5m€17.8m▼
Stocks30/36€7.3m€8.8m▲
Raw materials and consumables30/31€4.5m€5.6m▲
Work in progress32€309,024-
Finished goods33€1.7m€3.1m▲
Advance payments36€825,955€75,951▼
Contracts in progress37€12.1m€9.1m▼
Amounts receivable within one year40/41€7.8m€5.8m▼
Trade receivables40€7.5m€5.6m▼
Other amounts receivable41€387,030€272,643▼
Current investments50/53€3.0m€11.5m▲
Other investments51/53€3.0m€11.5m▲
Cash at bank and in hand54/58€15.5m€15.8m▲
Deferred charges and accrued income490/1€186,924€281,976▲
Equity and liabilities
Total equity and liabilities10/49€58.5m€62.6m▲
Equity10/15€31.0m€38.5m▲
Contributions10/11€6.4m€6.4m=
Capital10€6.4m€6.4m=
Issued capital100€17.4m€17.4m=
Uncalled capital101€11.0m€11.0m=
Reserves13€1.7m€1.7m=
Non-distributable reserves130/1€1.7m€1.7m=
Legal reserve130€1.7m€1.7m=
Profit (loss) carried forward14€22.9m€30.4m▲
Investment grants15€6,150€6,150=
Provisions and deferred taxes16€2.1m€2.1m▲
Provisions for liabilities and charges160/5€2.1m€2.1m▲
Major repairs and maintenance162€140,000-
Other liabilities and charges164/5€2.0m€2.1m▲
Amounts payable17/49€25.4m€22.0m▼
Amounts payable within one year42/48€25.1m€21.4m▼
Trade debts44€4.3m€916,748▼
Suppliers440/4€4.3m€916,748▼
Advances received on contracts in progress46€16.2m€11.2m▼
Taxes, remuneration and social security45€1.8m€1.8m▲
Taxes450/3€694,397€535,646▼
Remuneration and social security454/9€1.1m€1.3m▲
Other amounts payable47/48€2.8m€7.5m▲
Accrued charges and deferred income492/3€278,870€589,859▲
Income statement Code20232024
Operating income70/76A€35.7m€41.4m▲
Turnover70€26.6m€41.9m▲
Change in stocks of work in progress, finished goods and contracts in progress71€7.9m-€1.9m▼
Own construction capitalised72€810,124€909,086▲
Other operating income74€338,008€551,913▲
Operating charges60/66A€24.3m€25.9m▲
Goods for resale, raw materials and consumables60€12.6m€12.0m▼
Purchases600/8€14.5m€13.0m▼
Change in stocks: decrease (increase)609-€1.9m-€1.1m▲
Services and other goods61€4.6m€5.9m▲
Remuneration, social security and pensions62€4.6m€5.2m▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2.5m€2.8m▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€164,777-€72,634▼
Provisions for liabilities and charges: additions (uses and reversals)635/8-€396,325€9,644▲
Other operating charges640/8€208,783€62,677▼
Operating profit (loss)9901€11.3m€15.5m▲
Financial income75/76B€280,139€813,055▲
Recurring financial income75€280,139€813,055▲
Income from financial fixed assets750-€91,777
Income from current assets751€61,096€192,166▲
Other financial income752/9€219,043€529,112▲
Financial charges65/66B€706,815€292,480▼
Recurring financial charges65€706,815€292,480▼
Debt charges650€94,143€190,848▲
Other financial charges652/9€612,672€101,632▼
Profit (loss) for the period before taxes9903€10.9m€16.0m▲
Income taxes67/77€1.3m€998,666▼
Taxes670/3€1.3m€1.1m▼
Tax adjustments and reversals of tax provisions77-€101,821
Profit (loss) for the period9904€9.6m€15.0m▲
Profit (loss) for the period to be appropriated9905€9.6m€15.0m▲
Appropriation of the result
Profit (loss) to be appropriated9906€26.1m€37.9m▲
Profit (loss) brought forward from the previous period14P€16.5m€22.9m▲
Transfer to equity691/2€438,752-
To the legal reserve6920€438,752-
Profit to be distributed694/7€2.7m€7.5m▲
Return on contributions (dividend)694€2.7m€7.5m▲
Social balance
Average headcount (FTE)908740.847.7▲

The notes to these accounts (67 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20202021202220232024Change
Operating income70/76A-€23.9m€28.2m€35.7m€41.4m▲ 16.1%
Turnover70€19.5m€22.6m€23.0m€26.6m€41.9m▲ 57.2%
Change in stocks of work in progress, finished goods and contracts in progress71--€7,622€3.9m€7.9m-€1.9m▼ 125%
Own construction capitalised72-€908,770€1.0m€810,124€909,086▲ 12.2%
Other operating income74-€352,100€248,754€338,008€551,913▲ 63.3%
Operating charges60/66A-€16.8m€19.9m€24.3m€25.9m▲ 6.5%
Goods for resale, raw materials and consumables60-€8.3m€9.9m€12.6m€12.0m▼ 5.0%
Purchases600/8-€8.9m€8.4m€14.5m€13.0m▼ 10.0%
Change in stocks: decrease (increase)609--€593,539€1.5m-€1.9m-€1.1m▲ 43.5%
Services and other goods61-€3.4m€3.9m€4.6m€5.9m▲ 27.5%
Remuneration, social security and pensions62-€3.5m€4.0m€4.6m€5.2m▲ 11.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1.2m€1.5m€2.0m€2.5m€2.8m▲ 15.2%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4--€224,587€57,912€164,777-€72,634▼ 144%
Provisions for liabilities and charges: additions (uses and reversals)635/8--€127,439-€371,873-€396,325€9,644▲ 102%
Other operating charges640/8-€463,334€562,501€208,783€62,677▼ 70.0%
Operating profit (loss)9901€6.2m€7.1m€8.2m€11.3m€15.5m▲ 36.5%
Financial income75/76B-€207,810€258,245€280,139€813,055▲ 190%
Recurring financial income75€32,350€207,810€241,245€280,139€813,055▲ 190%
Income from financial fixed assets750----€91,777-
Income from current assets751-€295-€61,096€192,166▲ 215%
Other financial income752/9-€207,515€241,245€219,043€529,112▲ 142%
Non-recurring financial income76B--€17,000---
Financial charges65/66B-€118,017€283,866€706,815€292,480▼ 58.6%
Recurring financial charges65€95,946€118,017€266,866€706,815€292,480▼ 58.6%
Debt charges650€19,708€36,092€30,823€94,143€190,848▲ 103%
Other financial charges652/9-€81,925€236,043€612,672€101,632▼ 83.4%
Non-recurring financial charges66B--€17,000---
Profit (loss) for the period before taxes9903€6.1m€7.2m€8.2m€10.9m€16.0m▲ 46.6%
Income taxes67/77€115,180€238,755€251,000€1.3m€998,666▼ 24.6%
Taxes670/3-€240,340€311,340€1.3m€1.1m▼ 16.9%
Tax adjustments and reversals of tax provisions77-€1,585€60,340-€101,821-
Profit (loss) for the period9904€6.0m€7.0m€7.9m€9.6m€15.0m▲ 56.4%
Profit (loss) for the period to be appropriated9905€6.0m€7.0m€7.9m€9.6m€15.0m▲ 56.4%
Line20202021202220232024Change
Assets
Total assets20/58€24.5m€31.3m€42.3m€58.5m€62.6m▲ 7.1%
Fixed assets21/28€5.5m€7.1m€11.1m€12.5m€11.3m▼ 9.5%
Intangible fixed assets21€417,923€953,438€2.0m€1.8m€1.7m▼ 6.6%
Tangible fixed assets22/27€4.9m€5.9m€7.5m€9.2m€8.8m▼ 4.5%
Land and buildings22--€177,110€177,110€177,110=
Plant, machinery and equipment23-€1.3m€1.3m€1.0m€1.8m▲ 75.7%
Furniture and vehicles24-€69,766€51,369€49,699€96,650▲ 94.5%
Other tangible fixed assets26-€2.9m€2.4m€1.4m€448,564▼ 68.1%
Assets under construction and advance payments27-€1.6m€3.7m€6.5m€6.3m▼ 4.2%
Financial fixed assets28€200,171€215,171€1.5m€1.5m€830,921▼ 43.9%
Affiliated companies280/1-€15,000€1.3m€1.3m€630,000▼ 50.8%
Participating interests280-€15,000€630,000€630,000€630,000=
Amounts receivable281--€650,000€650,000--
Other financial fixed assets284/8-€200,171€200,171€200,171€200,921▲ 0.4%
Amounts receivable and cash guarantees285/8-€200,171€200,171€200,171€200,921▲ 0.4%
Current assets29/58€19.0m€24.2m€31.2m€46.0m€51.3m▲ 11.6%
Stocks and contracts in progress3€3.7m€7.1m€10.4m€19.5m€17.8m▼ 8.4%
Stocks30/36-€4.9m€5.9m€7.3m€8.8m▲ 19.7%
Raw materials and consumables30/31-€4.2m€2.6m€4.5m€5.6m▲ 23.6%
Work in progress32-€10,554€86,070€309,024--
Finished goods33-€224,988€1.7m€1.7m€3.1m▲ 85.4%
Advance payments36-€524,219€1.5m€825,955€75,951▼ 90.8%
Contracts in progress37-€2.2m€4.5m€12.1m€9.1m▼ 25.4%
Amounts receivable within one year40/41€3.7m€3.9m€6.4m€7.8m€5.8m▼ 25.5%
Trade receivables40-€3.3m€5.8m€7.5m€5.6m▼ 25.3%
Other amounts receivable41-€564,429€561,317€387,030€272,643▼ 29.6%
Current investments50/53€6.6m€4.5m€3.0m€3.0m€11.5m▲ 283%
Other investments51/53-€4.5m€3.0m€3.0m€11.5m▲ 283%
Cash at bank and in hand54/58€2.8m€8.7m€11.4m€15.5m€15.8m▲ 2.2%
Deferred charges and accrued income490/1-€77,612€98,109€186,924€281,976▲ 50.9%
Equity and liabilities
Total equity and liabilities10/49€24.5m€31.3m€42.3m€58.5m€62.6m▲ 7.1%
Equity10/15€13.5m€18.5m€24.2m€31.0m€38.5m▲ 24.2%
Contributions10/11€6.4m€6.4m€6.4m€6.4m€6.4m=
Capital10-€6.4m€6.4m€6.4m€6.4m=
Issued capital100-€17.4m€17.4m€17.4m€17.4m=
Uncalled capital101-€11.0m€11.0m€11.0m€11.0m=
Reserves13€550,621€899,772€1.3m€1.7m€1.7m=
Non-distributable reserves130/1-€899,772€1.3m€1.7m€1.7m=
Legal reserve130-€899,772€1.3m€1.7m€1.7m=
Profit (loss) carried forward14€6.6m€11.2m€16.5m€22.9m€30.4m▲ 32.8%
Investment grants15-€6,150€6,150€6,150€6,150=
Provisions and deferred taxes16€3.0m€2.9m€2.5m€2.1m€2.1m▲ 0.5%
Provisions for liabilities and charges160/5-€2.9m€2.5m€2.1m€2.1m▲ 0.5%
Major repairs and maintenance162-€140,000€140,000€140,000--
Other liabilities and charges164/5-€2.7m€2.4m€2.0m€2.1m▲ 7.6%
Amounts payable17/49€8.0m€10.0m€15.7m€25.4m€22.0m▼ 13.3%
Amounts payable after more than one year17€64,994-----
Amounts payable within one year42/48€7.9m€10.0m€15.6m€25.1m€21.4m▼ 14.7%
Current portion of amounts payable after more than one year42-€64,994----
Trade debts44€677,806€1.2m€2.0m€4.3m€916,748▼ 78.7%
Suppliers440/4-€1.2m€2.0m€4.3m€916,748▼ 78.7%
Advances received on contracts in progress46-€5.7m€9.9m€16.2m€11.2m▼ 30.9%
Taxes, remuneration and social security45-€1.0m€1.4m€1.8m€1.8m▲ 1.1%
Taxes450/3-€219,567€223,110€694,397€535,646▼ 22.9%
Remuneration and social security454/9-€799,374€1.2m€1.1m€1.3m▲ 16.0%
Other amounts payable47/48-€2.0m€2.3m€2.8m€7.5m▲ 166%
Accrued charges and deferred income492/3-€29,287€108,595€278,870€589,859▲ 112%
Line20202021202220232024Change
Profit (loss) for the period9904€6.0m€7.0m€7.9m€9.6m€15.0m▲ 56.4%
+ Depreciation and write-downs630€1.2m€1.5m€2.0m€2.5m€2.8m▲ 15.2%
Operating cash flow (approximation)€7.2m€8.5m€9.9m€12.0m€17.8m▲ 48.0%
Investment in fixed assets (approximation)--€3.1m-€5.9m-€3.9m-€1.6m▲ 57.5%
Change in cash-€5.9m€2.7m€4.1m€347,919▼ 91.6%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2025
21-10
State Gazette act Resignations & appointments
Nace code change · Management decision2 facts ▸
  • Nace code change, Modification des codes NACE suite à la fusion par absorption de Plast4life
  • Management decision
17-07
State Gazette act Purpose
Merger · Accounting effect · Share cancellation8 facts ▸
  • General meeting, 30-06-2025
  • Merger, absorption, 30-06-2025
  • Accounting effect, 01-01-2025
  • Share cancellation, all shares of PLAST4LIFE
  • Purpose change, La société a pour objet, pour son compte et pour le compte de tiers, tant en Belgique qu'à l'étranger, la recherche, le développement, l'étude, la fabrication,…
  • Share acquisition, 14-05-2025
  • Convertible bond repayment, 2024
  • Merger project, 15-05-2025, 23-05-2025
17-07
NBB filing Annual accounts filed
fiscal year 2024 · full schema
23-05
State Gazette act Restructuring
Permanent representatives: Patrick Baleriaux and Sophie Sauvage · Merger · Accounting effect11 facts ▸
  • Merger, absorption
  • Accounting effect, 01-01-2025
  • Purpose change, La société a pour objet, pour son compte et pour le compte de tiers, tant en Belgique qu'à l'étranger, la recherche, le développement, l'étude, la fabrication,…
  • Permanent representative, Patrick Baleriaux
  • Permanent representative, Sophie Sauvage
  • Share transfer, Aseptic Technologies → PLAST4LIFE
  • Bankruptcy, 03-10-2024
  • Shareholding, 55788
  • Shareholding, 6200
  • Merger terms
  • Merger execution, acte authentique, Gauthy
2024
31-12
Financial Highest result since 2018net €15.0m ▲56.4%
Operating result €15.5m, net result €15.0m, both a record.
12-12
State Gazette act Appointments: PKBX Management, Martin Steegmüller and 2 others
Permanent representatives: Patrick Balériaux and Sophie Sauvage · Mandate compensation · Director discharge9 facts ▸
  • General meeting, 09-10-2024
  • Director appointment, PKBX Management (managing director)
  • Permanent representative, Patrick Balériaux
  • Director appointment, Martin Steegmüller (director)
  • Director appointment, Burim Maraj (director)
  • Director appointment, Sparaxis (director)
  • Permanent representative, Sophie Sauvage
  • Mandate compensation, Aseptic Technologies
  • Director discharge, Aseptic Technologies
08-08
State Gazette act Resignation: Patrick Balériaux (managing director)
Appointment: PKBX Management SRL (managing director) · Permanent representative: Patrick Balériaux · Reappointment: BDO Réviseurs d'Entreprises (statutory auditor)7 facts ▸
  • General meeting, 26-06-2024
  • Director discharge, Asephe Technologies
  • Director resignation, Patrick Balériaux (managing director)
  • Director appointment, PKBX Management SRL (managing director)
  • Permanent representative, Patrick Balériaux
  • Auditor reappointment, BDO Réviseurs d'Entreprises
  • Board meeting, 19-10-2023
01-07
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial Equity above €25mEq €31.0m ▲28.4%
6 profitable years in a row build equity to €31.0m.
10-07
NBB filing Annual accounts filed
fiscal year 2022 · full schema
26-05
State Gazette act Resignation: DEGIVE Philippe (permanent representative)
Appointment: SAUVAGE Sophie (permanent representative) · Purpose change · Statutes amendment7 facts ▸
  • General meeting, 22-05-2023
  • Purpose change, La société a pour objet, pour son compte et pour le compte de tiers, tant en Belgique qu'à l'étranger, la recherche, le développement, la production, la commerc…
  • Statutes amendment
  • Capital, €17.356.640
  • Statutes amendment
  • Director resignation, DEGIVE Philippe (permanent representative)
  • Director appointment, SAUVAGE Sophie (permanent representative)
2022
11-08
NBB filing Annual accounts filed
fiscal year 2021 · full schema · 11 days late
Show earlier events
20-07
State Gazette act Resignations: Thomas Huber (director) and Christian Colson (director)
3 facts ▸
  • General meeting, 22-06-2022
  • Director resignation, Thomas Huber (director)
  • Director resignation, Christian Colson (director)
2021
24-08
State Gazette act Appointments: Patrick Balériaux, Martin Steegmüller and 2 others
Permanent representative: Pierre Paraire · Reappointment: BDO Réviseurs d'Entreprises (statutory auditor) · Mandate compensation12 facts ▸
  • General meeting, 23-06-2021
  • Director appointment, Patrick Balériaux (director)
  • Director appointment, Martin Steegmüller (director)
  • Director appointment, Sascha Pawel (director)
  • Director appointment, Sparaxis (director)
  • Permanent representative, Pierre Paraire
  • Mandate compensation, Patrick Balériaux
  • Mandate compensation, Martin Steegmüller
  • Mandate compensation, Sascha Pawel
  • Mandate compensation, Sparaxis
  • Auditor reappointment, BDO Réviseurs d'Entreprises
  • Director appointment, Patrick Balériaux (managing director)
06-07
NBB filing Annual accounts filed
fiscal year 2020 · full schema
2020
31-12
Financial Equity above €10mEq €13.5m ▲46.6%
3 profitable years in a row build equity to €13.5m.
07-07
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
06-12
State Gazette act Permanent representative: Christophe Pelzer
Term2 facts ▸
  • Permanent representative, Christophe Pelzer
  • Term, jusqu'au terme du mandat actuellement en cours, lequel expirera lors de l'assemblée générale ordinaire de 2021
12-07
NBB filing Annual accounts filed
fiscal year 2018 · full schema
01-03
State Gazette act Resignation: Volker Sigwarth (director)
Appointment: Sascha Pawel (director)3 facts ▸
  • General meeting, 31-01-2019
  • Director resignation, Volker Sigwarth (director)
  • Director appointment, Sascha Pawel (director)
2018
31-07
State Gazette act Appointment: BDO Réviseurs d'Entreprises (statutory auditor)
Mandate compensation3 facts ▸
  • General meeting, 27-06-2018
  • Auditor appointment, BDO Réviseurs d'Entreprises (statutory auditor)
  • Mandate compensation, BDO Réviseurs d'Entreprises
03-07
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
04-07
NBB filing Annual accounts filed
fiscal year 2016 · full schema
2016
25-07
State Gazette act Capital & shares · Statutes amendment
Capital decrease · Capital · Power of attorney6 facts ▸
  • General meeting, 27-06-2016
  • Capital decrease, €33.055.761,68
  • Capital, €17.356.640
  • Statutes amendment
  • Power of attorney, ASEPTIC TECHNOLOGIES
  • General meeting, 22-06-2016
22-07
State Gazette act Permanent representative: Pierre Paraire
Reappointments: Sparaxis, Patrick Balériaux and 2 others · Mandate compensation7 facts ▸
  • General meeting, 22-06-2016
  • Permanent representative, Pierre Paraire
  • Director reappointment, Sparaxis (director)
  • Director reappointment, Patrick Balériaux (managing director)
  • Director reappointment, Volker Sigwarth (director)
  • Director reappointment, Thomas Huber (director)
  • Mandate compensation, ASEPTIC TECHNOLOGIES
29-06
NBB filing Annual accounts filed
fiscal year 2015 · full schema
2015
23-09
State Gazette act Resignation: Luc Joris (director)
Appointment: BDO Réviseurs d'Entreprises (statutory auditor) · Permanent representative: Philippe Blanche4 facts ▸
  • General meeting, 24-06-2015
  • Director resignation, Luc Joris (director)
  • Auditor appointment, BDO Réviseurs d'Entreprises
  • Permanent representative, Philippe Blanche
2014
02-05
State Gazette act Resignation: PwC Réviseurs d'Entreprises (statutory auditor)
Appointment: BDO Réviseurs d'Entreprises (statutory auditor) · Mandate compensation4 facts ▸
  • General meeting, 27-06-2012
  • Director resignation, PwC Réviseurs d'Entreprises (statutory auditor)
  • Auditor appointment, BDO Réviseurs d'Entreprises (statutory auditor)
  • Mandate compensation, BDO Réviseurs d'Entreprises
2012
27-03
State Gazette act Resignation: Denis Dubru (director)
2 facts ▸
  • General meeting, 22-06-2011
  • Director resignation, Denis Dubru (director)
2011
21-06
State Gazette act Resignations: Jean STEPHENNE, Denis DUBRU and 4 others
Appointments: Luc JORIS, SPARAXIS SA and 4 others · Permanent representative: Christian COLSON · Share cancellation24 facts ▸
  • General meeting, 29-04-2011
  • Share cancellation, 18500, 37.001 à 55.500
  • Capital increase, €15.000.000
  • Capital, €50.412.401,68
  • Statutes amendment
  • Director resignation, Jean STEPHENNE (director)
  • Director resignation, Denis DUBRU (director)
  • Director resignation, Michel DUCHENE (director)
  • Director resignation, SPARAXIS SA (director)
  • Director resignation, Christian VANDECASSERIE (director)
  • Director resignation, Patrick BALERIAUX (director)
  • Director appointment, Luc JORIS (director)
  • +12 further facts in this act
2010
06-08
State Gazette act Reappointments: Jean Stéphenne, Denis Dubru and 3 others
Permanent representative: Christian Colson · Appointment: Michel Duchène (director) · Mandate compensation9 facts ▸
  • General meeting, 23-06-2010
  • Director reappointment, Jean Stéphenne (director)
  • Director reappointment, Denis Dubru (director)
  • Director reappointment, Patrick Balériaux (managing director)
  • Director reappointment, Christian Vandecasserie (director)
  • Director reappointment, Sparaxis (director)
  • Permanent representative, Christian Colson
  • Director appointment, Michel Duchène (director)
  • Mandate compensation, ASEPTIC TECHNOLOGIES
2008
31-07
State Gazette act Reappointments: Jean Stéphenne, Denis Dubru and 3 others
Permanent representative: Christian Colson · Mandate compensation8 facts ▸
  • General meeting, 25-06-2008
  • Director reappointment, Jean Stéphenne (director)
  • Director reappointment, Denis Dubru (director)
  • Director reappointment, Patrick Balériaux (managing director)
  • Director reappointment, Christian Vandecasserie (director)
  • Director reappointment, Sparaxis (director)
  • Permanent representative, Christian Colson
  • Mandate compensation, ASEPTIC TECHNOLOGIES
2007
24-07
State Gazette act Resignation: SPRL Arithmos (managing director)
Reappointments: Jean Stéphenne, Denis Dubru and 2 others · Permanent representative: Jacques Seron · Appointment: Christian Vandecasserie (director)9 facts ▸
  • General meeting, 27-06-2007
  • Director resignation, SPRL Arithmos (managing director)
  • Director reappointment, Jean Stéphenne (director)
  • Director reappointment, Denis Dubru (director)
  • Director reappointment, Patrick Balériaux (managing director)
  • Director reappointment, Sparaxis (director)
  • Permanent representative, Jacques Seron
  • Director appointment, Christian Vandecasserie (director)
  • Mandate compensation, ASEPTIC TECHNOLOGIES
2005
07-03
State Gazette act Appointment: Michel Lange (statutory auditor)
2 facts ▸
  • General meeting, 23-06-2004
  • Auditor appointment, Michel Lange (statutory auditor)
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
21 of 21 acts read

Directors · office · real estate

Directors
4 directors, 2 in day-to-day management, no change since 2024

Board 4

SPARAXIS
Director · since 29-04-2011 · Public limited company · perm. rep.: Jacques Seron
Current
Sascha Pawel
Director · since 31-01-2019
Current
Martin Steegmüller
Director · since 23-06-2021
Current
Burim Maraj
Director · since 09-10-2024
Current
2 not recently confirmed
Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.
Patrick Marcel BALERIAUX
Director · since 29-04-2011
Not recently confirmed
Thomas Martin HUBER
Director · since 29-04-2011
Not recently confirmed

Day-to-day management 2

PKBX MANAGEMENT SRL
Managing director · since 31-10-2023 · Legal entity · perm. rep.: Patrick Balériaux
Current
PKBX Management
Managing director · since 09-10-2024 · Legal entity · perm. rep.: Patrick Balériaux
Current

Permanent representatives 3

Jacques Seron
Permanent representative · since 29-04-2011 · for SPARAXIS
Current
SAUVAGE Sophie
Permanent representative · since 30-04-2023
Current
Patrick Balériaux
Permanent representative · since 09-10-2024 · for PKBX Management
Current

Statutory auditor 1

BDO Réviseurs d'Entreprises
Auditor · since 27-06-2012
Current
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Gembloux · 2 establishment units since 2002
seat establishment 1 of 2 establishment units on the map
Ground area
1,190 m²
Building footprint
606 m²
Volume, LiDAR
5,094 m³
Parcel 92065B0056/00H003, Wallonia · tallest building 10.9 m, ±3 floors. Linked by address, not a title deed.
2 establishment units
Rue Camille Hubert,Isnes 7-9, 5032 Gembloux
Manufacture of machinery and equipment not elsewhere classified
since 20022.093.448.357
Rue Bonne-Fortune 102, 4430 Ans
Manufacture of rubber and plastic products
since 20252.377.306.088
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
92065B0056/00H003 Wallonia 1,190 m² 1 · 606 m² 10.9 m · 3 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Mandate history

23 people since 2004, 10 in office
Show
  • Board
  • Day-to-day management
  • Permanent representative
  • Statutory auditor
  • not recently confirmed
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
SPARAXIS
  • Director, already before 24-07-2007 to date
Sascha Pawel
  • Director, from 31-01-2019 to date
Martin Steegmüller
  • Director, from 23-06-2021 to date
Burim Maraj
  • Director, from 09-10-2024 to date
PKBX MANAGEMENT SRL
  • Managing director, from 31-10-2023 to date
PKBX Management
  • Managing director, from 09-10-2024 to date
SAUVAGE Sophie
  • Permanent representative, from 30-04-2023 to date
BDO Réviseurs d'Entreprises
  • Auditor, from 27-06-2012 to date
Patrick Marcel BALERIAUX
  • Director, from 29-04-2011 not ended, last confirmed 21-06-2011
Thomas Martin HUBER
  • Director, from 29-04-2011 not ended, last confirmed 21-06-2011
Patrick Balériaux
  • Managing director, already before 24-07-2007 to 31-10-2023
  • Director, until 29-04-2011
  • Director, from 23-06-2021 ended, last mentioned 24-08-2021
DEGIVE Philippe
  • Permanent representative, until 30-04-2023
Christian COLSON
  • Director, until 22-06-2022
Thomas Huber
  • Director, already before 22-06-2016 to 22-06-2022
Volker Sigwarth
  • Director, from 29-04-2011 to 31-01-2019
Luc JORIS
  • Director, from 29-04-2011 to 24-06-2015
Michel Lange
  • Statutory auditor, from 23-06-2004 to 27-06-2012
PwC Reviseurs d'Entreprises
  • Statutory auditor, until 27-06-2012
Denis Dubru
  • Director, already before 24-07-2007 to 30-06-2011
Christian Vandecasserie
  • Director, from 27-06-2007 to 29-04-2011
Jean STEPHENNE
  • Director, already before 24-07-2007 to 29-04-2011
Michel Duchène
  • Director, from 23-06-2010 to 29-04-2011
SPRL Arithmos
  • Managing director, until 27-06-2007
See the board, name and seat on a given date →

Structure & network

Owners and holdings

2 owners · 1 holding

Chain of control

  1. Skan AGCH 90%
  2. ASEPTIC TECHNOLOGIES

Highest known parent: Skan AG (Switzerland). The sources do not say who stands above it.

Owners 2

Stated earlier (1)

An older source named these owners; newer accounts no longer list them.

Holdings 1

According to the 2024 annual accounts of ASEPTIC TECHNOLOGIES and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

19 connected companies
Linked via shared directors
Show 15 more companies with a shared director
FN Browning Group
Shared director
→
FN HERSTAL
Shared director
→
→
Fondation Saint - Luc
Shared director
→
→
→
Innosté
Shared director
→
n-Side
Shared director
→
NANOCYL
Shared director
→
OncoDNA
Shared director
→
SOPARTEC
Shared director
→

Acquisitions and mergers

1 transaction
Took over:PLAST4LIFE
BE 0776.531.322merger by absorption · State Gazette act of 17-07-2025 (2 acts) · effective 30-06-2025

Capital and shareholders

Shareholders according to the acts
Stated in the act act of 23-05-2025 ↗
  • SKAN AG 55,788 shares
  • WALLONIE ENTREPRENDRE SA 6,200 shares

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 26-05-2023 Capital stated in the act · 17,356,640 EUR · 61,988 shares
  2. 25-07-2016 Capital reduction of 33,055,761.68 EUR · to 17,356,640 EUR · to absorb losses
  3. 21-06-2011 Capital increase of 15,000,000 EUR · to 50,412,401.68 EUR · 24,988 new shares

Recognitions · licences · registrations

Legal Entity Identifier

254900C4U7XNTG9GWE31
live in the LEI register

Similar companies · same sector, comparable size

Of 346 companies in sector 28990 we hold annual accounts for 278. 40 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPublic limited company
Founded04-07-2002
Fiscal year end31-12
Activities, NACEBEL 2025
28990Manufacture of machinery and equipment not elsewhere classified
71121Engineering and related technical consultancy, excluding land surveyors
22220Manufacture of rubber and plastic products
E-invoicing
Reachable via Peppol
Peppol ID 0208:0477899303
Registered 22-09-2025

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.